II. Mechanism
- Non-Dihydropyridine Calcium Channel Blocker
- AV Node effects
- Reduces myocardial Oxygen Consumption
- Negative chronotropic effect
- Negative inotropic effect
- Reduces Systemic Vascular Resistance
- Results from vasodilatation of peripheral arteriole vascular Smooth Muscle
- Counters negative inotropic effect
- More negative hemodynamic effects than Diltiazem
- Coronary vasodilatation
III. Indications
- Diltiazem is typically the preferred Non-Dihydropyridine Calcium Channel Blocker
- Paroxysmal Supraventricular Tachycardia (90% effective)
-
Supraventricular Tachycardia
- Terminates AV Node reentry Tachycardias
- Slows ventricular response to Atrial Fibrillation
- Verapamil is highly effective
- Used for acute treatment and prevention
-
Hypertension
- Consider Dihydropyridine Calcium Channel Blocker (e.g. Amlodipine) instead if Heart Rate control not needed
-
Angina
- Decreases Anginal episodes
IV. Contraindications
-
Wolff-Parkinson-White Syndrome with Atrial Fibrillation
- Paroxysmal accelerated ventricular response
- Risk of progression into Ventricular Fibrillation
-
Wide Complex Tachycardia (unless supraventricular)
- Risk of severe Hypotension
- May progress into Ventricular Fibrillation
- Verapamil ineffective against Ventricular Tachycardia
- Sinus Node or AV Node dysfunction without Pacemaker
- Severe Congestive Heart Failure or LV Dysfunction
- Concurrent Intravenous Beta Blocker use
V. Dosing: Supraventricular Tachycardia in Adults
- Initial Dose: 2.5 to 5.0 mg (0.075 to 0.15 mg/kg) IV bolus over 2 to 3 min
- Subsequent: 5 to 10 mg IV every 15 to 30 min
- Maximum 30 mg total, cummulative dose
VI. Dosing: Supraventricular Tachycardia in Children (8-15 years old)
- Initial: 0.1 mg/kg up to 2.5 to 5 mg IV over 1-2 min
- Subsequent: 0.2 mg/kg up to 5 to 10 mg after 15 to 30 min
- Dose range: 0.1 to 0.3 mg/kg IV
VII. Dosing: Hypertension or Angina in Adults
- Do not chew or crush medication
- However scored tablets may be cut
- Sustained release capsules may be sprinkled on food
- Regular Release
- Start 40 to 80 mg orally three times daily
- Maximum 480 mg/day
- Extended Release
- Isoptin SR and Calan SR should be divided twice daily when daily dose >240 mg/day
- Start 120 to 240 mg orally daily
- Maximum 480 mg/day
VIII. Precautions: Transient Hypotension
- Results from peripheral vasodilation
- Countered by Intravenous Calcium Injection
- Consider prophylactic pretreatment with Calcium
IX. Adverse Effects
- See Calcium Channel Blocker
- Constipation (more than with Diltiazem)
- Peripheral Edema
- Congestive Heart Failure exacerbation
- Hypotension
- Bradycardia
- Gastrointestinal upset or Nausea
- Dizziness
X. Safety
- Pregnancy Category C
- Avoid in Lactation
XI. Drug Interactions
- Agents that prolong AV Node conduction (avoid)
- Beta Blockers
- Digoxin
- Clonidine (case reports of severe episodes)
- Ivabradine (contraindicated in combination)
- Agents with levels increased by Verapamil
- Digoxin (increases level >50%)
- Lovastatin (limit to 20 mg daily)
- Simvastatin (limit to 10 mg daily)
- Doxorubicin
- Agents that increase Verapamil levels
- Grapefruit Juice
- Cimetidine (reduces clearance)
- Other interactions
- Chemotherapy
- mTOR Inhibitors (e.g. Sirolimus)
- Prazosin (Hypotension)
- Calcium Supplement (inhibits Verapamil activity)
XII. Pharmacokinetics
- Peak effect seen within 3-5 minutes of bolus injection
- Serum half life 5 hours
- Prolonged up to 20 hours in Cirrhosis
XIII. Metabolism
- Well absorbed orally
- First pass metabolism 80% to active metabolites
- Highly Protein bound (90%)
- Exercise caution in liver or renal Impairment
XIV. Resources
- Verapamil Tablet (DailyMed)
- Verapamil Delayed Release Tablet (DailyMed)
- Verapamil Injection Solution (DailyMed)
XV. References
- (2022) Presc Lett, Resource #381108, Comparison of Calcium Channel Blockers
- (2020) Med Lett Drugs Ther 62(1598): 73-80
- Olson (2020) Clinical Pharmacology, Medmaster Miami, p. 70-1
- Hamilton (2020) Tarascon Pocket Pharmacopoeia
Images: Related links to external sites (from Bing)
Related Studies
verapamil (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
VERAPAMIL 120 MG TABLET | Generic | $0.07 each |
VERAPAMIL 40 MG TABLET | Generic | $0.13 each |
VERAPAMIL 80 MG TABLET | Generic | $0.06 each |
VERAPAMIL ER 120 MG CAPSULE | Generic | $1.14 each |
VERAPAMIL ER 120 MG TABLET | Generic | $0.25 each |
VERAPAMIL ER 180 MG CAPSULE | Generic | $1.14 each |
VERAPAMIL ER 180 MG TABLET | Generic | $0.20 each |
VERAPAMIL ER 240 MG CAPSULE | Generic | $1.30 each |
VERAPAMIL ER 240 MG TABLET | Generic | $0.16 each |
VERAPAMIL ER PM 100 MG CAPSULE | Generic | $4.62 each |
VERAPAMIL ER PM 200 MG CAPSULE | Generic | $5.66 each |
VERAPAMIL ER PM 300 MG CAPSULE | Generic | $8.37 each |
VERAPAMIL SR 120 MG CAPSULE | Generic | $1.14 each |
VERAPAMIL SR 180 MG CAPSULE | Generic | $1.14 each |
VERAPAMIL SR 240 MG CAPSULE | Generic | $1.30 each |
VERAPAMIL SR 360 MG CAPSULE | Generic | $4.52 each |